SCHEMBL13601628

SCHEMBL13601628

CCCCCCOC(=O)CCC(=O)N1CCC(C)CC1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.55
GNAI3 P08754 8/20 0.50
GNAO1 P09471 8/20 0.50
GNAI1 P63096 8/20 0.50
HTR2C P28335 1/20 0.49
HPGD P15428 2/20 0.48
LMNA P02545 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
NAAA Q02083 1/20 0.46
DGKA P23743 1/20 0.46
PRKCA P17252 2/20 0.45
POLB P06746 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601627 0.94 NPC1 (0.58) NPC1GNAI3GNAO1GNAI1HPGD
SCHEMBL13601626 0.88 NPC1 (0.57) NPC1GNAI3GNAO1GNAI1HPGD
SCHEMBL12881491 0.85 GNAI3 (0.69) GNAI3GNAO1GNAI1HTR2CLMNA
SCHEMBL13601633 0.83 NPC1 (0.55) NPC1HPGDLMNAALDH1A1MEN1
SCHEMBL13601661 0.83 HTR2C (0.51) GNAI3GNAO1GNAI1HTR2CLMNA
SCHEMBL12881511 0.82 GNAI3 (0.51) GNAI3GNAO1GNAI1HTR2CLMNA
SCHEMBL14879738 0.82 NPC1 (0.76) NPC1GNAI3GNAO1GNAI1HPGD
SCHEMBL3365303 0.82 NPC1 (0.76) NPC1GNAI3GNAO1GNAI1HPGD
SCHEMBL13601407 0.82 NAAA (0.47) HTR2CKMT2ANAAADGKAPOLB
SCHEMBL13601630 0.80 NPC1 (0.54) NPC1HPGDLMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed